Second China-Made mRNA Covid Shot Approved Overseas

A messenger RNA-based Covid-19 vaccine developed by Chinese biotech firm Stemirna Therapeutics won approval for emergency use in Laos, the second China-made mRNA shot cleared for public inoculation outside the country.

The Laos Food and Drug Department cleared the Stemirna inoculation Thursday for use in people ages 18 and older. The vaccine is designed to protect people against new virus variants including delta and omicron.